Status:
COMPLETED
Optimal Timing of Intrauterine Insemination (IUI) When Utilizing Superovulation Combined With GnRH Antagonists
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Infertility
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The timing of IUI following ovulation induction has been the subject of many studies and a consensus has developed that a single insemination approximately thirty-six hours after ovulation induction i...
Eligibility Criteria
Inclusion
- Women with infertility who are candidates for controlled ovarian stimulation and intrauterine insemination with
- Ovulatory disorder
- male factor
- partial mechanical factor
- endometriosis
- unexplained infertility.
Exclusion
- Known allergy to one or more of the utilized drugs
- Neither fallopian tube is patent
- Sperm count less than 1 million total motile sperm of normal morphology during at least two investigations
- Women who are candidates for mono-ovulation.
- failure to receive consent
- women with baseline functional cysts (i.e. hormone producing) above 12 mm diameter.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00675142
Start Date
May 1 2008
End Date
August 1 2011
Last Update
June 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HaEmek Medical Center
Afula, Israel, 18101